Incident users of tyrosine kinase inhibitors in patients with chronic myeloid leukemia: Analysis of anticancer treatment trajectories-A French population-based study using the French national health data system

被引：2
|
作者：
Vabre, Clementine [1 ,2 ]
Zelmat, Yoann [3 ]
Gauthier, Martin [4 ,5 ]
Pajiep, Marie [3 ]
Conte, Cecile [3 ]
Lapeyre-Mestre, Maryse [2 ,3 ]
Dray-Spira, Rosemary [1 ]
Zureik, Mahmoud [1 ]
Despas, Fabien [2 ,3 ,6 ]
机构：
[1] French Natl Agcy Safety Med & Hlth Prod & French, EPI PHARE Sci Interest Grp Epidemiol Hlth Prod, Paris, France
[2] Univ Paul Sabatier Toulouse, Toulouse Univ Hosp, INSERM, Equipe PEPS,CIC 1436, Toulouse, France
[3] Toulouse Univ Hosp, Fac Med, Ctr PharmacoVigilance & Pharmacoepidemiol, Dept Med & Clin Pharmacol, Toulouse, France
[4] Toulouse Univ Hosp, Inst Univ Canc Oncopole, Dept Hematol, Toulouse, France
[5] Cahors Hosp, Dept Hematol, Cahors, France
[6] Univ Toulouse III, Inst Malad Metabol & Cardiovasc I2MC, UMR1297, INSERM DR Midi Pyrenees Limousin, Toulouse, France
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2022年 / 97卷 / 08期
关键词：
D O I：
10.1002/ajh.26621
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E307 / E309
页数：3
相关论文
共 37 条
  • [1] Incident users of protein kinase inhibitors in chronic myeloid leukemia: analysis of anticancer treatment courses and comedications-A French population-based study using the French national health data system
    Vabre, C.
    Zelmat, Y.
    Gauthier, M.
    Pajiep, M.
    Conte, C.
    Lapeyre-Mestre, M.
    Dray-Spira, R.
    Zureik, M.
    Despas, F.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 : 140 - 141
  • [2] The treatment of patients with chronic myeloid leukemia chronic phase combined with myelofibrosis with tyrosine kinase inhibitors: A Chinese population-based study
    Zhang, Xinlu
    Yang, Xiudi
    Chen, Dan
    Wang, Yi
    Feng, Weiying
    Lu, Ying
    Qian, Honglan
    Zhou, Mei
    Chen, Yu
    Wu, Dijiong
    Liu, Lirong
    Tong, Hongyan
    Jin, Jie
    Huang, Jian
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [3] Impact of tyrosine kinase inhibitors on work life in Chronic Myeloid Leukemia : Analysis from the French national health insurance database
    Vayr, F.
    Conte, C.
    Pajiep, M.
    Despas, F.
    Huguet, F.
    Lapeyre-Mestre, M.
    Gauthier, M.
    Herin, F.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 : 127 - 128
  • [4] The impact of introducing tyrosine kinase inhibitors on chronic myeloid leukemia survival: a population-based study
    Di Felice, Enza
    Roncaglia, Francesca
    Venturelli, Francesco
    Mangone, Lucia
    Luminari, Stefano
    Cirilli, Claudia
    Carrozzi, Giuliano
    Rossi, Paolo Giorgi
    BMC CANCER, 2018, 18
  • [5] The impact of introducing tyrosine kinase inhibitors on chronic myeloid leukemia survival: a population-based study
    Enza Di Felice
    Francesca Roncaglia
    Francesco Venturelli
    Lucia Mangone
    Stefano Luminari
    Claudia Cirilli
    Giuliano Carrozzi
    Paolo Giorgi Rossi
    BMC Cancer, 18
  • [6] Survival of chronic myeloid leukemia patients in comparison to the general population in the tyrosine kinase inhibitors era: A US population-based study
    Jamy, Omer
    Godby, Richard
    Sarmad, Rehan
    Costa, Luciano J.
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (07) : E265 - E268
  • [7] Cardiovascular Events Associated With Use of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia A Population-Based Cohort Study
    Dahlen, Torsten
    Edgren, Gustaf
    Lambe, Mats
    Hoglund, Martin
    Bjorkholm, Magnus
    Sandin, Fredrik
    Sjalander, Anders
    Richter, Johan
    Olsson-Stromberg, Ulla
    Ohm, Lotta
    Back, Magnus
    Stenke, Leif
    ANNALS OF INTERNAL MEDICINE, 2016, 165 (03) : 161 - +
  • [8] TNF-alpha inhibitors biosimilar use in France: a nationwide population-based study using the French National Health Data System
    Hugo Jourdain
    Léa Hoisnard
    Emilie Sbidian
    Mahmoud Zureik
    Scientific Reports, 12
  • [9] TNF-alpha inhibitors biosimilar use in France: a nationwide population-based study using the French National Health Data System
    Jourdain, Hugo
    Hoisnard, Lea
    Sbidian, Emilie
    Zureik, Mahmoud
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [10] Drug-drug interactions of protein kinase inhibitors in chronic myeloid leukemia patients: A study using the French health insurance database
    Pajiep, M. C.
    Lapeyre-Mestre, M.
    Despas, F.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 : 99 - 99
1234